Report Detail
Global Liraglutide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2940129 |
- 14 February, 2019 |
- Global |
- 119 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
Scope of the Report:
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in 'Type 2 diabetes: the management of type 2 diabetes'
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
The worldwide market for Liraglutide is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Liraglutide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pills
Liquid
Market Segment by Applications, can be divided into
Hospital
Drug Store
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liraglutide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liraglutide, with price, sales, revenue and global market share of Liraglutide in 2017 and 2018.
Chapter 3, the Liraglutide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liraglutide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liraglutide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liraglutide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Liraglutide Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Pills
- 1.2.2 Liquid
- 1.3 Market Analysis by Applications
- 1.3.1 Hospital
- 1.3.2 Drug Store
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 HEC Pharm
- 2.1.1 Business Overview
- 2.1.2 Liraglutide Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 HEC Pharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Bachem
- 2.2.1 Business Overview
- 2.2.2 Liraglutide Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Bachem Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Bharat Pharmaceuticals
- 2.3.1 Business Overview
- 2.3.2 Liraglutide Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Bharat Pharmaceuticals Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Kingpep Biotechnology
- 2.4.1 Business Overview
- 2.4.2 Liraglutide Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Kingpep Biotechnology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Shenzhen JYMed Technology
- 2.5.1 Business Overview
- 2.5.2 Liraglutide Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Shenzhen JYMed Technology Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Wuxi Asiapeptide
- 2.6.1 Business Overview
- 2.6.2 Liraglutide Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Wuxi Asiapeptide Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 AmbioPharm
- 2.7.1 Business Overview
- 2.7.2 Liraglutide Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 AmbioPharm Liraglutide Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Liraglutide Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Liraglutide Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Liraglutide Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Liraglutide Manufacturer Market Share in 2018
- 3.3.2 Top 6 Liraglutide Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Liraglutide Market Analysis by Regions
- 4.1 Global Liraglutide Sales, Revenue and Market Share by Regions
- 4.1.1 Global Liraglutide Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Liraglutide Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Liraglutide Sales and Growth Rate (2014-2019)
- 4.3 Europe Liraglutide Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Liraglutide Sales and Growth Rate (2014-2019)
- 4.5 South America Liraglutide Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Liraglutide Sales and Growth Rate (2014-2019)
5 North America Liraglutide by Country
- 5.1 North America Liraglutide Sales, Revenue and Market Share by Country
- 5.1.1 North America Liraglutide Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Liraglutide Revenue and Market Share by Country (2014-2019)
- 5.2 United States Liraglutide Sales and Growth Rate (2014-2019)
- 5.3 Canada Liraglutide Sales and Growth Rate (2014-2019)
- 5.4 Mexico Liraglutide Sales and Growth Rate (2014-2019)
6 Europe Liraglutide by Country
- 6.1 Europe Liraglutide Sales, Revenue and Market Share by Country
- 6.1.1 Europe Liraglutide Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Liraglutide Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Liraglutide Sales and Growth Rate (2014-2019)
- 6.3 UK Liraglutide Sales and Growth Rate (2014-2019)
- 6.4 France Liraglutide Sales and Growth Rate (2014-2019)
- 6.5 Russia Liraglutide Sales and Growth Rate (2014-2019)
- 6.6 Italy Liraglutide Sales and Growth Rate (2014-2019)
7 Asia-Pacific Liraglutide by Country
- 7.1 Asia-Pacific Liraglutide Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Liraglutide Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Liraglutide Revenue and Market Share by Country (2014-2019)
- 7.2 China Liraglutide Sales and Growth Rate (2014-2019)
- 7.3 Japan Liraglutide Sales and Growth Rate (2014-2019)
- 7.4 Korea Liraglutide Sales and Growth Rate (2014-2019)
- 7.5 India Liraglutide Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Liraglutide Sales and Growth Rate (2014-2019)
8 South America Liraglutide by Country
- 8.1 South America Liraglutide Sales, Revenue and Market Share by Country
- 8.1.1 South America Liraglutide Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Liraglutide Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Liraglutide Sales and Growth Rate (2014-2019)
- 8.3 Argentina Liraglutide Sales and Growth Rate (2014-2019)
- 8.4 Colombia Liraglutide Sales and Growth Rate (2014-2019)
9 Middle East and Africa Liraglutide by Countries
- 9.1 Middle East and Africa Liraglutide Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Liraglutide Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Liraglutide Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Liraglutide Sales and Growth Rate (2014-2019)
- 9.3 Turkey Liraglutide Sales and Growth Rate (2014-2019)
- 9.4 Egypt Liraglutide Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Liraglutide Sales and Growth Rate (2014-2019)
- 9.6 South Africa Liraglutide Sales and Growth Rate (2014-2019)
10 Global Liraglutide Market Segment by Type
- 10.1 Global Liraglutide Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Liraglutide Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Liraglutide Revenue and Market Share by Type (2014-2019)
- 10.2 Pills Sales Growth and Price
- 10.2.1 Global Pills Sales Growth (2014-2019)
- 10.2.2 Global Pills Price (2014-2019)
- 10.3 Liquid Sales Growth and Price
- 10.3.1 Global Liquid Sales Growth (2014-2019)
- 10.3.2 Global Liquid Price (2014-2019)
11 Global Liraglutide Market Segment by Application
- 11.1 Global Liraglutide Sales Market Share by Application (2014-2019)
- 11.2 Hospital Sales Growth (2014-2019)
- 11.3 Drug Store Sales Growth (2014-2019)
12 Liraglutide Market Forecast (2019-2024)
- 12.1 Global Liraglutide Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Liraglutide Market Forecast by Regions (2019-2024)
- 12.2.1 North America Liraglutide Market Forecast (2019-2024)
- 12.2.2 Europe Liraglutide Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Liraglutide Market Forecast (2019-2024)
- 12.2.4 South America Liraglutide Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Liraglutide Market Forecast (2019-2024)
- 12.3 Liraglutide Market Forecast by Type (2019-2024)
- 12.3.1 Global Liraglutide Sales Forecast by Type (2019-2024)
- 12.3.2 Global Liraglutide Market Share Forecast by Type (2019-2024)
- 12.4 Liraglutide Market Forecast by Application (2019-2024)
- 12.4.1 Global Liraglutide Sales Forecast by Application (2019-2024)
- 12.4.2 Global Liraglutide Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Liraglutide . Industry analysis & Market Report on Liraglutide is a syndicated market report, published as Global Liraglutide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Liraglutide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
